Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Lars Rebien Sørensen
AddedMar 31, 2024
UpdatedMay 1, 2026
Lars Rebien Sørensen

Lars Rebien Sørensen

Board Member, Novo Nordisk Fonden

Lars Rebien Sørensen's Career

Novo Nordisk Fonden
Novo Nordisk Fonden

Hellerup, Capital Region of Denmark, DK

Board Member· Board
Ferring
Ferring

Saint-Prex, canton Vaud, CH

Board Member· Board
Novo Holdings
Novo Holdings

Hellerup, Capital Region of Denmark, DK

Board Member· Board
Thermo Fisher th
Thermo Fisher th

Waltham, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Lars Rebien Sørensen's Career

Novo Nordisk Fonden
Novo Nordisk Fonden
NonprofitNonprofit1711923Hellerup, Capital Region of Denmark, DK
Board Member· Board

Leadership at Novo Nordisk Fonden

Liselotte HøjgaardLiselotte HøjgaardBoard Member
Mads Krogsgaard ThomsenMads Krogsgaard ThomsenCEO
Sten ScheibyeSten ScheibyeBoard Member
Lars MunchLars MunchBoard Member
Marianne PhilipMarianne PhilipBoard Member
Steen RiisgaardSteen RiisgaardBoard Member

Similar to Novo Nordisk Fonden

FærchfondenFærchfondenHolstebro, Central Denmark Region, DKEntrepreneurshipest. 1969FærchfondenHolstebro, Central Denmark Region, DK · est. 1969

Denmark-based Færch Foundation fosters growth and innovation by supporting entrepreneurship, business, and education.

Nonprofit9
NorrskenNorrskenStockholm, Stockholm County, SEVenture Capitalest. 2016NorrskenStockholm, Stockholm County, SE · est. 2016

Sweden-based Norrsken Foundation is a non-profit providing early-stage venture capital for impact tech entrepreneurs globally.

Nonprofit95
Alfred P. Sloan FoundationAlfred P. Sloan FoundationNew York City, NY, USEducation, Grantsest. 1934Alfred P. Sloan FoundationNew York City, NY, US · est. 1934

Alfred P. Sloan Foundation: A US philanthropic nonprofit, established in 1934, by ex-GM CEO.

Nonprofit62
Lenfest FoundationLenfest FoundationWest Conshohocken, PA, USest. 2000Lenfest FoundationWest Conshohocken, PA, US · est. 2000

Lenfest Foundation Inc.: Providing scholarships and grants for education, arts, and environment.

Nonprofit6
Ferring
Ferring
Public$490M7k1950Saint-Prex, canton Vaud, CH
Board Member· Board

Leadership at Ferring

Hélène PloixHélène PloixBoard Member
Paul NavarrePaul NavarreCEO
Luzi Andreas von BidderLuzi Andreas von BidderBoard Member
Frederik PaulsenFrederik PaulsenBoard Member
JAN PEUTZFELDTJAN PEUTZFELDTBoard Member
GIANPIERO REVERBERIGIANPIERO REVERBERIBoard Member

Similar to Ferring

Vifor PharmaVifor PharmaGlattbrugg, Zürich, CHPharmaceuticalsest. 2008Vifor PharmaGlattbrugg, Zürich, CH · est. 2008

Global pharmaceutical company specializing in iron deficiency, nephrology, and cardio-renal therapies.

Public2.8k
SanofiSanofiParis, Paris, FRPharmaceuticalsest. 1973SanofiParis, Paris, FR · est. 1973

Sanofi, a global French pharmaceutical firm, manufactures prescription drugs and vaccines, specializing in various medical fields.

Public · $610M91.6k
Kyntra BioKyntra BioSan Francisco, CA, USPharmaceuticalsest. 1993Kyntra BioSan Francisco, CA, US · est. 1993

FibroGen, Inc: A global, research-based pharmaceutical company in San Francisco, innovating treatments for unmet medical needs.

Public · $188M592
Bayer PharmaceuticalsBayer PharmaceuticalsBerlin, Berlin, DEDrugs, Pharmaceuticalsest. 2003Bayer PharmaceuticalsBerlin, Berlin, DE · est. 2003

Bayer Pharmaceuticals: A global enterprise specializing in biochemical research and drug manufacturing since 2008.

Public10k
Novo Holdings
Novo Holdings
Investment FirmInvestment Firm3111999Hellerup, Capital Region of Denmark, DK
Board Member· Board

Recent news

Quantonation’s double-sized second fund shows quantum still has believersTechCrunch · 2026

Leadership at Novo Holdings

Jodi YangJodi YangFounder
Per Wold-OlsenPer Wold-OlsenBoard Member
Kasim KutayKasim KutayCEO

Similar to Novo Holdings

Novo VenturesNovo VenturesCopenhagen, Capital Region of Denmark, DKest. 1999Novo VenturesCopenhagen, Capital Region of Denmark, DK · est. 1999

Danish-based Novo A/S, a private holding company, is fully owned by the Novo Nordisk Foundation.

Investment Firm32
Novo HoldingNovo HoldingLund, Skåne County, SEest. 1999Novo HoldingLund, Skåne County, SE · est. 1999

Novo Holding, a diversified financial services firm in Sweden, excels in sectors from telecom to energy, and invests in innovative technologies.

Investment Firm30
Novo SeedsNovo SeedsDenmark, SC, USNovo SeedsDenmark, SC, US

Investing in Nordic startups to develop transformative products.

Investment Firm175
Novator PartnersNovator PartnersLondon, Greater London, GBest. 2005Novator PartnersLondon, Greater London, GB · est. 2005

Novator: A global private equity firm, investing in developed and emerging markets since 2004.

Investment Firm35
Thermo Fisher th
Thermo Fisher th
Public$119B130k2006Waltham, MA, US
Board Member· Board

Leadership at Thermo Fisher th

Martin HarrisMartin HarrisBoard Member
Dion WeislerDion WeislerBoard Member
Ruby ChandyRuby ChandyBoard Member
Tyler JacksTyler JacksBoard Member
Scott SperlingScott SperlingBoard Member
Debora SparDebora SparBoard Member

Similar to Thermo Fisher th

Portal BiotechnologiesPortal BiotechnologiesWatertown, MA, USest. 2023Portal BiotechnologiesWatertown, MA, US · est. 2023

Portal Biotechnologies is a Watertown, Massachusetts-based cell engineering and drug discovery platform company founded in 2023.

Series A · $9M
Bio-RadBio-RadHercules, CA, USDiagnostics, Life Scienceest. 1952Bio-RadHercules, CA, US · est. 1952

Bio-Rad Laboratories: A leading biotech firm specializing in life science research, clinical diagnostics, and analytical instrumentation.

Public · $1.2B8k
FluidigmFluidigmSouth San Francisco, CA, USBiotechnologyest. 1999FluidigmSouth San Francisco, CA, US · est. 1999

Standard BioTools Inc., based in South San Francisco, accelerates life sciences research with essential, standardized technologies.

Public615
RevvityRevvityWaltham, MA, USLife Science Researchest. 1937RevvityWaltham, MA, US · est. 1937

PerkinElmer: A global leader in diagnostics, life science research, and industrial testing, operating in 190 countries.

Public16.7k

Lars Rebien Sørensen's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Lars Rebien Sørensen

Lars Nørby JohansenLars Nørby JohansenBoard Member · DemantNiels JacobsenNiels JacobsenBoard Member · MaerskHenning Holck-LarsenHenning Holck-LarsenCo-Founder · Larsen & ToubroRasmus ReferRasmus ReferBoard Member · WikisoftSteffen KraghSteffen KraghBoard Member · Lundbeckfond Ventures